13 reports

MOBILE Mobile advertising has primarily driven social media ad spend by pharmaceutical & healthcare brands, accounting for ##%, in 2015.

  • Advertising
  • Computer
  • Pharmaceutical
  • Web 2.0
  • Tencent Holdings Ltd

FIGURE ##: CHINA RETAIL BRANDS' ONLINE ADVERTISING SPEND - SPLIT BY MOBILE AND DESKTOP (US$ MILLION), 2015 VS. 2020 ##. ## Pharmaceutical & Healthcare Online Ad Spend Being among the few countries that allow direct to consumer marketing of pharmaceutical products, digital ad

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd

MOBILE Mobile advertising has primarily driven social media ad spend by pharmaceutical & healthcare brands, accounting for ##%, in 2014.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Web 2.0
  • Tencent Holdings Ltd

FIGURE ##: CHINA PHARMACEUTICAL & HEALTHCARE BRANDS' ONLINE ADVERTISING SPEND (US$ MILLION), 2010-2019 ##. ##. ## SNAPSHOT, 2010-2019 FIGURE ##: CHINA PHARMACEUTICAL & HEALTHCARE BRANDS' ONLINE ADVERTISING SPEND - BREAKDOWN BY MARKETING OBJECTIVE (%), 2014VS. 2019 Bran

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • Neuralstem Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017
  • Neuralstem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017
  • Pharmaceutical
  • United States
  • Company
  • Company Operations
  • Neuralstem, Inc.
  • TEIJIN PHARMA LTD
  • OPTIC NEURITIS - PIPELINE BY NEURALSTEM INC, H1 2017
  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Neuralstem, Inc.
  • NOVALEAD PHARMA PVT LTD
  • PIPELINE BY COMPANIES
  • Neurological Disorder
  • Pathology
  • Pharmaceutical
  • Therapy
  • Neuralstem, Inc.
  • Acute Spinal Cord Injury - Therapeutics under Development by Companies

Kringle Pharma is headquartered in Osaka, Japan Kringle Pharma, Inc.

  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Product Initiative
  • Neuralstem, Inc.
  • Number of Products under Development by Companies, H1 2015

Kringle Pharma, Inc.

  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Product Initiative
  • Neuralstem, Inc.
  • NERVE INJURY - PIPELINE BY NEURALSTEM, INC., H1 2016
  • Nerve Injury - Companies Involved in Therapeutics Development

Its products include active pharmaceutical ingredients (APIs), pharmaceutical ingredients and cell gene therapies.

  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Neuralstem, Inc.
  • Marathon Pharmaceuticals, LLC
  • Products under Development by Companies, H2 2015
  • Dementia
  • Pharmaceutical
  • Therapy
  • United States
  • Neuralstem, Inc.
  • Marathon Pharmaceuticals, LLC
  • Products under Development by Companies, H1 2015
  • Dementia
  • Pharmaceutical
  • United States
  • Product Initiative
  • Neuralstem, Inc.

Aug ##, 2010 BMN-## Was Discontinued By BioMarin Pharmaceuticals Inc.

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Neuralstem, Inc.